RLN3 Gene

HGNC Family Endogenous ligands
Name relaxin 3
Description This gene encodes a member of the relaxin family of insulin-like hormones that is expressed predominantly in the brain and plays a role in physiological processes such as stress, memory and appetite regulation. The encoded protein is a precursor that is proteolytically processed to generate a heterodimeric mature form consisting A and B chains interlinked by disulfide bonds. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2015]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRelaxin‐3 (RLN3) is a member of the insulin/relaxin peptide superfamily that has been molecularly characterized as a two‐chain hormone held together by disulfide bonds, with a unique conformation revealed by nuclear magnetic resonance studies. Early biochemical studies identified RLN3 as the endogenous ligand for orphan G protein–coupled receptors such as GPCR135 (RXFP3) and GPCR142, and extensive structure–activity work—including the use of chimeric peptides and A‐chain substitutions—has elucidated that conserved residues (for example, key arginines and hydrophobic motifs within its B‐chain) are critical for high‐affinity receptor binding and for triggering efficient signal transduction. Detailed mutagenesis experiments further established the importance of complementary electrostatic and hydrophobic interactions between RLN3 and its receptors, and structural comparisons have differentiated its interactions with RXFP3/GPCR135 versus other related receptors."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nWithin the central nervous system RLN3 is predominantly expressed in discrete brainstem nuclei – notably the nucleus incertus – with extensive projections to hypothalamic and limbic regions. Functional neuropharmacological studies have demonstrated that central administration of RLN3 robustly increases food intake and modulates arousal, stress responses, and emotional behaviors through activation of RXFP3, engaging inhibitory G protein pathways and downstream MAPK signaling cascades. Moreover, pharmacological tools such as selective antagonists and biased agonists have refined our understanding of its receptor–mediated effects, while studies in primate tissue and ex vivo preparations underline neuroprotective actions and a potential role in the modulation of depressive‐ and anxiety‐like behaviors."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its central neuromodulatory roles, RLN3 has been implicated in a range of peripheral physiological processes. Experimental studies have shown that RLN3 can exert antifibrotic effects in cardiac fibroblasts by antagonizing profibrotic signals via RXFP1, and its circulating levels have been associated with acute heart failure. Moreover, clinical investigations have linked RLN3 with metabolic regulation and components of the metabolic syndrome, while genetic and hormonal studies have suggested roles in reproductive development and even in the timing of puberty. However, candidate gene approaches exploring associations with neuropsychiatric outcomes have produced mixed results, highlighting the need for further research on this pleiotropic peptide."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Changlu Liu, Jingcai Chen, Steven Sutton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of relaxin-3/INSL7 as a ligand for GPCR142."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M308996200"}], "href": "https://doi.org/10.1074/jbc.M308996200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14522967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14522967"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Changlu Liu, Elo Eriste, Steven Sutton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M308995200"}], "href": "https://doi.org/10.1074/jbc.M308995200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14522968"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14522968"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Changlu Liu, Jingcai Chen, Chester Kuei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.104.006700"}], "href": "https://doi.org/10.1124/mol.104.006700"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15465925"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15465925"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Geoffrey W Tregear, Ross A Bathgate, Sharon Layfield, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The chemistry and biology of human relaxin-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann N Y Acad Sci (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1196/annals.1282.008"}], "href": "https://doi.org/10.1196/annals.1282.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15956686"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15956686"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Emma T Van der Westhuizen, Patrick M Sexton, Ross A D Bathgate, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Responses of GPCR135 to human gene 3 (H3) relaxin in CHO-K1 cells determined by microphysiometry."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann N Y Acad Sci (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1196/annals.1282.053"}], "href": "https://doi.org/10.1196/annals.1282.053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15956730"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15956730"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "K Johan Rosengren, Feng Lin, Ross A D Bathgate, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M511210200"}], "href": "https://doi.org/10.1074/jbc.M511210200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16365033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16365033"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Mohammed Akhter Hossain, K Johan Rosengren, Linda M Haugaard-Jönsson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M801911200"}], "href": "https://doi.org/10.1074/jbc.M801911200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18434306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18434306"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wei-Jie Zhang, Xin-Yi Wang, Yu-Qi Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The highly conserved negatively charged Glu141 and Asp145 of the G-protein-coupled receptor RXFP3 interact with the highly conserved positively charged arginine residues of relaxin-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Amino Acids (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00726-014-1705-3"}], "href": "https://doi.org/10.1007/s00726-014-1705-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24615237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24615237"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Xin-Yi Wang, Yu-Qi Guo, Wei-Jie Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.12830"}], "href": "https://doi.org/10.1111/febs.12830"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24802387"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24802387"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Meng-Jun Hu, Xiao-Xia Shao, Jia-Hui Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of hydrophobic interactions between relaxin-3 and its receptor RXFP3: implication for a conformational change in the B-chain C-terminus during receptor binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Amino Acids (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00726-016-2260-x"}], "href": "https://doi.org/10.1007/s00726-016-2260-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27193232"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27193232"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yu Liu, Lei Zhang, Xiao-Xia Shao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A negatively charged transmembrane aspartate residue controls activation of the relaxin-3 receptor RXFP3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2016.06.013"}], "href": "https://doi.org/10.1016/j.abb.2016.06.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27353281"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27353281"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Tharindunee Jayakody, Subhi Marwari, Rajamani Lakshminarayanan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hydrocarbon stapled B chain analogues of relaxin-3 retain biological activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Peptides (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.peptides.2016.08.001"}], "href": "https://doi.org/10.1016/j.peptides.2016.08.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27498038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27498038"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Sheng Y Ang, Dana S Hutchinson, Bronwyn A Evans, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Naunyn Schmiedebergs Arch Pharmacol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00210-016-1321-8"}], "href": "https://doi.org/10.1007/s00210-016-1321-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27888281"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27888281"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "B M C McGowan, S A Stanley, K L Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Central relaxin-3 administration causes hyperphagia in male Wistar rats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2004-1532"}], "href": "https://doi.org/10.1210/en.2004-1532"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15845619"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15845619"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mohammed Akhter Hossain, Ross A D Bathgate, K Johan Rosengren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chem Biol Drug Des (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1747-0285.2008.00756.x"}], "href": "https://doi.org/10.1111/j.1747-0285.2008.00756.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19152634"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19152634"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Josh D Silvertown, Anton Neschadim, Hsueh-Ning Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Regul Pept (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.regpep.2009.09.007"}], "href": "https://doi.org/10.1016/j.regpep.2009.09.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19778557"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19778557"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Craig M Smith, Philip J Ryan, Ihaia T Hosken, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relaxin-3 systems in the brain--the first 10 years."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Chem Neuroanat (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jchemneu.2011.05.013"}], "href": "https://doi.org/10.1016/j.jchemneu.2011.05.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21693186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21693186"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "M Kocan, M Sarwar, M A Hossain, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bph.12623"}], "href": "https://doi.org/10.1111/bph.12623"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24641548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24641548"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Alan Kania, Marian H Lewandowski, Anna Błasiak "}, {"type": "b", "children": [{"type": "t", "text": "[Relaxin-3 and relaxin family peptide receptors--from structure to functions of a newly discovered mammalian brain system]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Postepy Hig Med Dosw (Online) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5604/17322693.1110163"}], "href": "https://doi.org/10.5604/17322693.1110163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24988606"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24988606"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Win Lee Edwin Wong, Gavin Stewart Dawe, Allan H Young "}, {"type": "b", "children": [{"type": "t", "text": "The putative role of the relaxin-3/RXFP3 system in clinical depression and anxiety: A systematic literature review."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Biobehav Rev (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neubiorev.2021.09.028"}], "href": "https://doi.org/10.1016/j.neubiorev.2021.09.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34537263"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34537263"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Ida Vogel, Mads Vilhelm Hollegaard, David Michael Hougaard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in the promoter region of relaxin-2 and preterm birth: involvement of relaxin in the etiology of preterm birth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "In Vivo (2009)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20023247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20023247"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Mohammed Akhter Hossain, Bryna Chow Suet Man, Chongxin Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi1013968"}], "href": "https://doi.org/10.1021/bi1013968"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21229994"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21229994"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Maivel H Ghattas, Eman T Mehanna, Noha M Mesbah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relaxin-3 is associated with metabolic syndrome and its component traits in women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Biochem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clinbiochem.2012.09.018"}], "href": "https://doi.org/10.1016/j.clinbiochem.2012.09.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23018057"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23018057"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xiaohui Zhang, Minling Zhu, Meng Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The plasma levels of relaxin-2 and relaxin-3 in patients with diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Biochem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clinbiochem.2013.08.007"}], "href": "https://doi.org/10.1016/j.clinbiochem.2013.08.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23994775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23994775"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Eva Thorell, Laura Goldsmith, Gerson Weiss, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Physical fitness, serum relaxin and duration of gestation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Pregnancy Childbirth (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12884-015-0607-z"}], "href": "https://doi.org/10.1186/s12884-015-0607-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26272327"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26272327"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Mariana Pintalhao, Paulo Castro-Chaves, Francisco Vasques-Novoa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Heart Fail (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ejhf.611"}], "href": "https://doi.org/10.1002/ejhf.611"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27488261"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27488261"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "S Hanafy, J H Sabry, E M Akl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum relaxin-3 hormone relationship to male delayed puberty."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Andrologia (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/and.12882"}], "href": "https://doi.org/10.1111/and.12882"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28786126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28786126"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Win Lee Edwin Wong, Ryan Arathimos, Cathryn M Lewis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Investigating the role of the relaxin-3/RXFP3 system in neuropsychiatric disorders and metabolic phenotypes: A candidate gene approach."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0294045"}], "href": "https://doi.org/10.1371/journal.pone.0294045"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37967073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37967073"}]}]}]}
Synonyms ZINS4, INSL7, RXN3, H3
Proteins REL3_HUMAN
NCBI Gene ID 117579
API
Download Associations
Predicted Functions View RLN3's ARCHS4 Predicted Functions.
Co-expressed Genes View RLN3's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View RLN3's ARCHS4 Predicted Functions.

Functional Associations

RLN3 has 2,554 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 79 datasets.

Click the + buttons to view associations for RLN3 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of RLN3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of RLN3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of RLN3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of RLN3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of RLN3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of RLN3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of RLN3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of RLN3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of RLN3 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of RLN3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of RLN3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of RLN3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing RLN3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with RLN3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with RLN3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of RLN3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with RLN3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with RLN3 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with RLN3 gene/protein from the curated CTD Gene-Disease Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by RLN3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with RLN3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with RLN3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with RLN3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with RLN3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at RLN3 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of RLN3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of RLN3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing RLN3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with RLN3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with RLN3 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with RLN3 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing RLN3 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of RLN3 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of RLN3 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of RLN3 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of RLN3 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of RLN3 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of RLN3 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Cellular Component Annotations 2015 cellular components containing RLN3 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by RLN3 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by RLN3 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by RLN3 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of RLN3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with RLN3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with RLN3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with RLN3 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with RLN3 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of RLN3 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of RLN3 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with RLN3 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by RLN3 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for RLN3 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of RLN3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of RLN3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of RLN3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways 2026 pathways involving RLN3 protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of RLN3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of RLN3 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain RLN3 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by RLN3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of RLN3 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by RLN3 gene mutations from the MPO Gene-Phenotype Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for RLN3 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of RLN3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of RLN3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving RLN3 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving RLN3 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2014 pathways involving RLN3 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving RLN3 protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of RLN3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at RLN3 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of RLN3 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of RLN3 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of RLN3 gene from the RummaGEO Gene Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of RLN3 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of RLN3 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of RLN3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with RLN3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with RLN3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.